GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
| 
                               
                            
                                
                                                                Synonyms: AG-221 | CC-90007 | Idhifa®
                                 
                                                         
                            
                            
                            
                                 
                                
                                enasidenib is an approved drug (FDA (2017)) 
                                                        
                                                    
                                Compound class: 
                                                            Synthetic organic
                                 
                                
                                    
                                        Comment: Enasidenib (AG-221) is an orally available inhibitor of isocitrate dehygrogenase 2 (IDH2), that is approved as an antineoplastic agent. This compound is example 409 in patent US20130190287 A1 [1].
                                    
                                 
                            
                            
                          
                                
                                    
                                
                          
                                   
                                   
                                  
                                      
                                     
                                   
                                   
                                    
                                    
                                     | 
                                    
                                        
                                         
  | 
                                    
                                
                                |||||||||||||||||||||||||||||||||||
Classification ![]()  | 
                                                    |
| Compound class | Synthetic organic | 
| Approved drug? | Yes. US FDA (2017) | 
IUPAC Name ![]()  | 
                                                        
| 2-methyl-1-[[4-[6-(trifluoromethyl)pyridin-2-yl]-6-[[2-(trifluoromethyl)pyridin-4-yl]amino]-1,3,5-triazin-2-yl]amino]propan-2-ol | 
International Nonproprietary Names ![]()  | 
                                                        |
| INN number | INN | 
| 10162 | enasidenib | 
Synonyms ![]()  | 
                                                        
| AG-221 | CC-90007 | Idhifa® | 
Database Links ![]()  | 
                                                        |
| CAS Registry No. | 1446502-11-9 (source: WHO INN record) | 
| DrugCentral Ligand | 5251 | 
| GtoPdb PubChem SID | 310264741 | 
| PubChem CID | 89683805 | 
| RCSB PDB Ligand | 69Q | 
| Search Google for chemical match using the InChIKey | DYLUUSLLRIQKOE-UHFFFAOYSA-N | 
| Search Google for chemicals with the same backbone | DYLUUSLLRIQKOE | 
| Search PubMed clinical trials | enasidenib | 
| Search PubMed titles | enasidenib | 
| Search PubMed titles/abstracts | enasidenib | 
| UniChem Compound Search for chemical match using the InChIKey | DYLUUSLLRIQKOE-UHFFFAOYSA-N | 
| UniChem Connectivity Search for chemical match using the InChIKey | DYLUUSLLRIQKOE-UHFFFAOYSA-N | 
Product supplier links are provided as a service to assist in identifying commercial suppliers of reagents that are mentioned on the IUPHAR/BPS Guide to PHARMACOLOGY database website, and do not imply their endorsement by NC-IUPHAR.
Links are provided in return for sponsorship, used to fund improvements to this database. The sponsorship account is managed and audited by the University of Edinburgh, a charitable body registered in Scotland, SC005336. If you are interested in sponsoring the database, please contact us.
✖| 
                                                                     
                                                                         
                                                                         
                                                                             
                                                                         
                                                                         
                                                                           
                                                                           Enasidenib (links to external site) 
                                                                    
                                                                Cat. No. HY-18690  |